Market Capitalization (Millions $) |
38 |
Shares
Outstanding (Millions) |
28 |
Employees |
- |
Revenues (TTM) (Millions $) |
80 |
Net Income (TTM) (Millions $) |
-9 |
Cash Flow (TTM) (Millions $) |
-5 |
Capital Exp. (TTM) (Millions $) |
12 |
Rockwell Medical Inc
Rockwell Medical Inc. is a pharmaceutical company that specializes in the development, manufacturing, and commercialization of medicines and medical devices for the treatment of chronic kidney disease (CKD). The company's primary focus is on providing innovative solutions to patients with kidney disorders, striving to improve their quality of life. Rockwell Medical's products include dialysis concentrates, iron replacement therapies, and hemodialysis systems. The company is committed to advancing the standard of care for CKD patients through its research and development efforts.
Company Address: 30142 S. Wixom Road Wixom 48393 MI
Company Phone Number: 960-9009 Stock Exchange / Ticker: NASDAQ RMTI
RMTI is expected to report next financial results on March 29, 2024. |
|
|